BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23707547)

  • 21. Cytogenetic Study and Analysis of Protein Expression in Plasma Cell Myeloma with t(11;14)(q13;q32): Absence of BCL6 and SOX11, and Infrequent Expression of CD20 and PAX5.
    Yokoi S; Sakai H; Uchida A; Uemura Y; Sato K; Tsuruoka Y; Nishio Y; Matsunawa M; Suzuki Y; Isobe Y; Kato M; Inoue Y; Hoshikawa M; Miura I
    J Clin Exp Hematop; 2015; 55(3):137-43. PubMed ID: 26763361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma.
    Yegappan S; Coupland R; Arber DA; Wang N; Miocinovic R; Tubbs RR; Hsi ED
    Mod Pathol; 2001 Nov; 14(11):1147-56. PubMed ID: 11706077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of flow cytometry in subtyping composite and sequential lymphoma.
    Siebert JD; Mulvaney DA; Vukov AM; Knost JA; King DE; Craig FE
    J Clin Lab Anal; 1999; 13(5):199-204. PubMed ID: 10494126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment?
    Clavio M; Quintino S; Venturino C; Ballerini F; Varaldo R; Gatto S; Galbusera V; Garrone A; Grasso R; Canepa L; Miglino M; Pierri I; Gobbi M
    J Exp Clin Cancer Res; 2001 Sep; 20(3):351-8. PubMed ID: 11718214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fine-needle cytology and flow cytometry immunophenotyping and subclassification of non-Hodgkin lymphoma: a critical review of 307 cases with technical suggestions.
    Zeppa P; Marino G; Troncone G; Fulciniti F; De Renzo A; Picardi M; Benincasa G; Rotoli B; Vetrani A; Palombini L
    Cancer; 2004 Feb; 102(1):55-65. PubMed ID: 14968418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sinusoidal CD30-positive large B-cell lymphoma: a morphologic mimic of anaplastic large cell lymphoma.
    Lai R; Medeiros LJ; Dabbagh L; Formenti KS; Coupland RW
    Mod Pathol; 2000 Mar; 13(3):223-8. PubMed ID: 10757332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of some leucocyte differentiation markers and the adenosine deaminase and purine nucleoside phosphorylase values in B and T cell leukemias and lymphomas.
    Mesárosová A; Hrivnáková A; Babusíková O
    Neoplasma; 1995; 42(6):307-12. PubMed ID: 8592572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric immunophenotyping in fine-needle aspiration of lymph nodes.
    Chung J; Gong G; Huh J; Khang SK; Ro JY
    J Korean Med Sci; 1999 Aug; 14(4):393-400. PubMed ID: 10485618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Composite cutaneous T-cell lymphoma and small B-cell lymphocytic lymphoma: morphologic, immunologic, and molecular genetic documentation of concurrent lymph node involvement.
    Liu YC; Tomashefski JF; Cleveland RP; Nassar SJ; Trey JE
    Mod Pathol; 1994 Aug; 7(6):641-6. PubMed ID: 7991522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of surface and cytoplasmic immunoglobulin light/heavy chains by flow cytometry using a lysed-whole-blood technique: Implications for the differential diagnosis of B-cell malignancies.
    Babusíková O; Stevulová L
    Neoplasma; 2004; 51(6):422-30. PubMed ID: 15640950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
    Laane E; Tani E; Björklund E; Elmberger G; Everaus H; Skoog L; Porwit-MacDonald A
    Cytometry B Clin Cytom; 2005 Mar; 64(1):34-42. PubMed ID: 15669024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunophenotypic analysis of Waldenstrom's macroglobulinemia.
    San Miguel JF; Vidriales MB; Ocio E; Mateo G; Sánchez-Guijo F; Sánchez ML; Escribano L; Bárez A; Moro MJ; Hernández J; Aguilera C; Cuello R; García-Frade J; López R; Portero J; Orfao A
    Semin Oncol; 2003 Apr; 30(2):187-95. PubMed ID: 12720134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Instability of immunophenotype in plasma cell myeloma.
    Cao W; Goolsby CL; Nelson BP; Singhal S; Mehta J; Peterson LC
    Am J Clin Pathol; 2008 Jun; 129(6):926-33. PubMed ID: 18480010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. t(11;14) Plasma cell disorder presents as a true nonsecretory, nonproducer multiple myeloma.
    Chen W; Namara MM; Kim Y; Huang Q
    Clin Lymphoma Myeloma; 2009 Jun; 9(3):243-6. PubMed ID: 19525195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgM myeloma: case report with immunophenotypic profile.
    Haghighi B; Yanagihara R; Cornbleet PJ
    Am J Hematol; 1998 Dec; 59(4):302-8. PubMed ID: 9840911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunophenotypic features by multiparameter flow cytometry can help distinguish low grade B-cell lymphomas with plasmacytic differentiation from plasma cell proliferative disorders with an unrelated clonal B-cell process.
    Rosado FG; Morice WG; He R; Howard MT; Timm M; McPhail ED
    Br J Haematol; 2015 May; 169(3):368-76. PubMed ID: 25644063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A common clonal origin of nodal marginal zone B-cell lymphoma and plasma cell myeloma demonstrating different immunophenotypes: a case report of composite lymphoma.
    Saito H; Oka K; Nakamura N; Nagayama R; Hakozaki H; Mori N
    Diagn Mol Pathol; 2004 Jun; 13(2):75-80. PubMed ID: 15167008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].
    Iguchi T; Miyazawa K; Okabe S; Kawakubo K; Shimamoto T; Kuriyama Y; Ito Y; Kimura Y; Ohyashiki K; Serizawa H; Iwaya K; Mukai K
    Rinsho Ketsueki; 2004 Oct; 45(10):1129-34. PubMed ID: 15553050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.